-
1
-
-
0022628932
-
A new international staging system for lung cancer
-
C.F. Mountain A new international staging system for lung cancer Chest 89 1986 225S 233S (Pubitemid 16138265)
-
(1986)
Chest
, vol.89
, Issue.4 SUPPL.
-
-
Mountain, C.F.1
-
2
-
-
0024357179
-
Value of the new TNM staging system for lung cancer
-
C.F. Mountain Value of the new TNM staging system for lung cancer Chest 96 1989 47S 49S (Pubitemid 19173091)
-
(1989)
Chest
, vol.96
, Issue.1 SUPPL.
-
-
Mountain, C.F.1
-
3
-
-
0023913018
-
Prognostic implications of the international staging system for lung cancer
-
C.F. Mountain Prognostic implications of the international staging system for lung cancer Semin Oncol 15 1988 236 245
-
(1988)
Semin Oncol
, vol.15
, pp. 236-245
-
-
Mountain, C.F.1
-
4
-
-
18744432910
-
Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: Analysis of the literature
-
DOI 10.1016/S0169-5002(97)00072-X, PII S016950029700072X
-
J.F. Vansteenkiste, P.R. De Leyn, and G.J. Deneffe et al. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature Lung Cancer 19 1998 3 13 (Pubitemid 28044078)
-
(1998)
Lung Cancer
, vol.19
, Issue.1
, pp. 3-13
-
-
Vansteenkiste, J.F.1
De Leyn, P.R.2
Deneffe, G.J.3
Lerut, T.E.4
Demedts, M.G.5
-
5
-
-
33646156881
-
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study
-
D.C. Betticher, S.F.H. Schmitz, and M. Tötsch et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study Br J Cancer 94 2006 1099 1106
-
(2006)
Br J Cancer
, vol.94
, pp. 1099-1106
-
-
Betticher, D.C.1
Schmitz, S.F.H.2
Tötsch, M.3
-
6
-
-
0346238665
-
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer
-
DOI 10.1056/NEJMoa031644
-
R. Arriagada, B. Bergman, and A. Dunant et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360 (Pubitemid 38101630)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.4
, pp. 351-360
-
-
Arriagada, R.1
Bergman, B.2
Dunant, A.3
Le Chevalier, T.4
Pignon, J.-P.5
Vansteenkiste, J.6
-
7
-
-
33747847740
-
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial
-
DOI 10.1016/S1470-2045(06)70804-X, PII S147020450670804X
-
J.Y. Douillard, R. Rosell, and M. De Lena et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial [J] Lancet Oncol 7 2006 719 727 (Pubitemid 44283661)
-
(2006)
Lancet Oncology
, vol.7
, Issue.9
, pp. 719-727
-
-
Douillard, J.-Y.1
Rosell, R.2
De Lena, M.3
Carpagnano, F.4
Ramlau, R.5
Gonzales-Larriba, J.L.6
Grodzki, T.7
Pereira, J.R.8
Le Groumellec, A.9
Lorusso, V.10
Clary, C.11
Torres, A.J.12
Dahabreh, J.13
Souquet, P.-J.14
Astudillo, J.15
Fournel, P.16
Artal-Cortes, A.17
Jassem, J.18
Koubkova, L.19
His, P.20
Riggi, M.21
Hurteloup, P.22
more..
-
8
-
-
20544455590
-
Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer
-
DOI 10.1056/NEJMoa043623
-
T. Winton, R. Livingston, and D. Johnson et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597 (Pubitemid 41007845)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.25
, pp. 2589-2597
-
-
Winton, T.1
Livingston, R.2
Johnson, D.3
Rigas, J.4
Johnston, M.5
Butts, C.6
Cormier, Y.7
Goss, G.8
Inculet, R.9
Vallieres, E.10
Fry, W.11
Bethune, D.12
Ayoub, J.13
Ding, K.14
Seymour, L.15
Graham, B.16
Tsao, M.-S.17
Gandara, D.18
Kesler, K.19
Demmy, T.20
Shepherd, F.21
more..
-
9
-
-
0032566225
-
Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled
-
Port Meta-Analysis Trialists Group
-
PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled Lancet 352 1998 257 263
-
(1998)
Lancet
, vol.352
, pp. 257-263
-
-
-
10
-
-
33745999736
-
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database
-
DOI 10.1200/JCO.2005.04.6110
-
B.E. Lally, D. Zelterman, and J.M. Colasanto et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database J Clin Oncol 24 2006 2998 3006 (Pubitemid 46638932)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.19
, pp. 2998-3006
-
-
Lally, B.E.1
Zelterman, D.2
Colasanto, J.M.3
Haffty, B.G.4
Detterbeck, F.C.5
Wilson, L.D.6
-
11
-
-
77951963496
-
A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease
-
B. Zou, Y. Xu, and T. Li et al. A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease Int J Radiat Oncol Biol Phys 77 2010 321 328
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.77
, pp. 321-328
-
-
Zou, B.1
Xu, Y.2
Li, T.3
-
12
-
-
77953958601
-
Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients
-
V. Scotti, I. Meattini, and C. Saieva et al. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients Radiother Oncol 96 2010 84 88
-
(2010)
Radiother Oncol
, vol.96
, pp. 84-88
-
-
Scotti, V.1
Meattini, I.2
Saieva, C.3
-
13
-
-
34247862308
-
A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer
-
DOI 10.1097/01.JTO.0000263710.54073.b3, PII 0124389420070400000007
-
S.J. Feigenberg, A.L. Hanlon, and C. Langer et al. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer J Thorac Oncol 2 2007 287 292 (Pubitemid 47181710)
-
(2007)
Journal of Thoracic Oncology
, vol.2
, Issue.4
, pp. 287-292
-
-
Feigenberg, S.J.1
Hanlon, A.L.2
Langer, C.3
Goldberg, M.4
Nicolaou, N.5
Millenson, M.6
Coia, L.R.7
Lanciano, R.8
Movsas, B.9
-
14
-
-
20644457720
-
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705
-
J.D. Bradley, R. Paulus, and M.V. Graham et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705 J Clin Oncol 23 2005 3480 3487
-
(2005)
J Clin Oncol
, vol.23
, pp. 3480-3487
-
-
Bradley, J.D.1
Paulus, R.2
Graham, M.V.3
-
15
-
-
10744228140
-
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
-
DOI 10.1016/S1053-4296(03)00031-6
-
A. Trotti, A.D. Colevas, and A. Setser et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181 (Pubitemid 36962641)
-
(2003)
Seminars in Radiation Oncology
, vol.13
, Issue.3
, pp. 176-181
-
-
Trotti, A.1
Colevas, A.D.2
Setser, A.3
Rusch, V.4
Jaques, D.5
Budach, V.6
Langer, C.7
Murphy, B.8
Cumberlin, R.9
Coleman, C.N.10
Rubin, P.11
-
16
-
-
38349075836
-
Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer
-
H. Melek, M. Gunluoglu, and A. Demir et al. Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer Eur J Cardiothorae Surg 33 2008 294 299
-
(2008)
Eur J Cardiothorae Surg
, vol.33
, pp. 294-299
-
-
Melek, H.1
Gunluoglu, M.2
Demir, A.3
-
17
-
-
20544455590
-
Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer
-
DOI 10.1056/NEJMoa043623
-
T.L. Winton, R. Livingston, and D. Johnson et al. Vinorelbine plus cisplatin vs observation in resected non-small cell lung cancer N Engl J Med 352 2005 2589 2597 (Pubitemid 41007845)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.25
, pp. 2589-2597
-
-
Winton, T.1
Livingston, R.2
Johnson, D.3
Rigas, J.4
Johnston, M.5
Butts, C.6
Cormier, Y.7
Goss, G.8
Inculet, R.9
Vallieres, E.10
Fry, W.11
Bethune, D.12
Ayoub, J.13
Ding, K.14
Seymour, L.15
Graham, B.16
Tsao, M.-S.17
Gandara, D.18
Kesler, K.19
Demmy, T.20
Shepherd, F.21
more..
-
18
-
-
0345872083
-
Multidisciplinary Management of Lung Cancer
-
DOI 10.1056/NEJMra035536
-
A. Spira, and D. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392 (Pubitemid 38101633)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.4
, pp. 379-392
-
-
Spira, A.1
Ettinger, D.S.2
-
19
-
-
0032566197
-
What now for postoperative radiotherapy for lung cancer?
-
DOI 10.1016/S0140-6736(98)22030-7
-
A.J. Munro What now for postoperative radiotherapy for lung cancer? Lancet 352 1998 250 251 (Pubitemid 28340137)
-
(1998)
Lancet
, vol.352
, Issue.9124
, pp. 250-251
-
-
Munro, A.J.1
-
20
-
-
52949137370
-
Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial
-
J.Y. Douillard, R. Rosell, and M. De Lena et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial Int J Radiat Oncol Biol Phys 72 2008 695 701
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 695-701
-
-
Douillard, J.Y.1
Rosell, R.2
De Lena, M.3
-
21
-
-
79956286590
-
Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: A retrospective study of 221 cases from a single institution
-
H. Dai, Z. Hui, and W. Ji et al. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution The Oncologist 16 2011 641 650
-
(2011)
The Oncologist
, vol.16
, pp. 641-650
-
-
Dai, H.1
Hui, Z.2
Ji, W.3
-
22
-
-
75449108663
-
Prognostic factors for resected non-small cell lung cancer with pN2 status: Implications for use of postoperative radiotherapy
-
L. Moretti, D.S. Yu, and H. Chen et al. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy The Oncologist 14 2009 1106 1115
-
(2009)
The Oncologist
, vol.14
, pp. 1106-1115
-
-
Moretti, L.1
Yu, D.S.2
Chen, H.3
-
23
-
-
84865817651
-
Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients
-
S.L. Govaert, E.G. Troost, and O.C. Schuurbiers et al. Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients Radiat Oncol 7 2012 1 7
-
(2012)
Radiat Oncol
, vol.7
, pp. 1-7
-
-
Govaert, S.L.1
Troost, E.G.2
Schuurbiers, O.C.3
-
24
-
-
12144290515
-
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer
-
DOI 10.1016/j.ijrobp.2003.09.086, PII S0360301603020832
-
H. Murshed, H.H. Liu, and Z. Liao et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1258 1267 (Pubitemid 38314812)
-
(2004)
International Journal of Radiation Oncology Biology Physics
, vol.58
, Issue.4
, pp. 1258-1267
-
-
Murshed, H.1
Liu, H.H.2
Liao, Z.3
Barker, J.L.4
Wang, X.5
Tucker, S.L.6
Chandra, A.7
Guerrero, T.8
Stevens, C.9
Change, J.Y.10
Jeter, M.11
Cox, J.D.12
Komaki, R.13
Mohan, R.14
-
25
-
-
12844271279
-
Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma
-
DOI 10.1016/j.ijrobp.2004.06.260, PII S0360301604026793
-
J. Bradley, M.V. Graham, and K. Winter et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328 (Pubitemid 40164423)
-
(2005)
International Journal of Radiation Oncology Biology Physics
, vol.61
, Issue.2
, pp. 318-328
-
-
Bradley, J.1
Graham, M.V.2
Winter, K.3
Purdy, J.A.4
Komaki, R.5
Roa, W.H.6
Ryu, J.K.7
Bosch, W.8
Emami, B.9
-
26
-
-
0033566002
-
A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma
-
DOI 10.1002/(SICI)1097-0142(19990715) 86:2<265::AID-CNCR10>3.0. CO;2-B
-
B. Dautzenberg, R. Arriagada, and A.B. Chammard et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma Cancer 8 1999 265 273 (Pubitemid 29327583)
-
(1999)
Cancer
, vol.86
, Issue.2
, pp. 265-273
-
-
Dautzenberg, B.1
Arriagada, R.2
Chammard, A.B.3
Jarema, A.4
Mezzetti, M.5
Mattson, K.6
Lagrange, J.L.7
Le Pechoux, C.8
Lebeau, B.9
Chastang, C.10
Marzecki, Z.11
Santos Miranda, J.A.12
Le Chevalier, T.13
Stankiewicz, D.14
Volterrani, F.15
Leclerc, P.16
Maasilta, P.17
Guerin, R.A.18
-
27
-
-
84883155079
-
Target volume for postoperative radiotherapy in non-small cell lung cancer: Results from a prospective trial
-
L. Kȩpka, K. Bujko, and M. Bujko et al. Target volume for postoperative radiotherapy in non-small cell lung cancer: results from a prospective trial Radiother Oncol 108 2013 61 65
-
(2013)
Radiother Oncol
, vol.108
, pp. 61-65
-
-
Kȩpka, L.1
Bujko, K.2
Bujko, M.3
-
28
-
-
79951855591
-
Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy
-
L. Kepka, K. Bujko, and T.M. Orlowski et al. Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy Radiother Oncol 98 2011 238 243
-
(2011)
Radiother Oncol
, vol.98
, pp. 238-243
-
-
Kepka, L.1
Bujko, K.2
Orlowski, T.M.3
-
29
-
-
0031137302
-
Survival and prognosis factors in resected N2 non-small cell lung cancer: A study of 140 cases
-
DOI 10.1016/S0003-4975(97)00314-7, PII S0003497597003147
-
J.F. Vansteenkiste, P.R. DeLeyn, and G.J. Deneffe et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases Ann Thorac Surg 63 1997 1441 1450 (Pubitemid 27239740)
-
(1997)
Annals of Thoracic Surgery
, vol.63
, Issue.5
, pp. 1441-1450
-
-
Vansteenkiste, J.F.1
De Leyn, P.R.2
Deneffe, G.J.3
Stalpaert, G.4
Nackaerts, K.L.5
Lerut, T.E.6
Demedts, M.G.7
-
30
-
-
50449109594
-
The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 nonsmall cell lung cancer
-
J.G. Lee, C.Y. Lee, and I.K. Park et al the prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 nonsmall cell lung cancer J Korean Med Sci 23 2008 604 608
-
(2008)
J Korean Med Sci
, vol.23
, pp. 604-608
-
-
Lee, J.G.1
Lee, C.Y.2
Park, I.K.3
-
31
-
-
49249138420
-
Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: Focusing on an effect of the number of mediastinal lymph node stations involved
-
H. Matsuguma, R. Nakahara, and Y. Ishikawa et al. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved Interact Cardiovasc Thorac Surg 7 2008 573 577
-
(2008)
Interact Cardiovasc Thorac Surg
, vol.7
, pp. 573-577
-
-
Matsuguma, H.1
Nakahara, R.2
Ishikawa, Y.3
-
32
-
-
0030778502
-
Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks
-
DOI 10.1016/S0003-4975(97)00908-9
-
T. Sawyer, J. Bonner, and P.M. Gould et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks Ann Thorac Surg 64 1997 1402 1407 (Pubitemid 127738778)
-
(1997)
Annals of Thoracic Surgery
, vol.64
, Issue.5
, pp. 1402-1407
-
-
Sawyer, T.E.1
Bonner, J.A.2
Gould, P.M.3
Foote, R.L.4
Deschamps, C.5
Trastek, V.F.6
Pairolero, P.C.7
Allen, M.S.8
Lange, C.M.9
Li, H.10
-
33
-
-
0033836428
-
Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer
-
S.M. Keller, S. Adak, and H. Wagner et al. Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Ann Thorac Surg 70 2000 358 365
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 358-365
-
-
Keller, S.M.1
Adak, S.2
Wagner, H.3
-
34
-
-
67649660400
-
Preoperative staging of lung cancer with combined PET-CT
-
B. Fischer, U. Lassen, and J. Mortensen et al. Preoperative staging of lung cancer with combined PET-CT N Engl J Med 361 2009 32 39
-
(2009)
N Engl J Med
, vol.361
, pp. 32-39
-
-
Fischer, B.1
Lassen, U.2
Mortensen, J.3
-
35
-
-
84859732438
-
PET/CT in the staging of the non-small-cell lung cancer
-
F. Chao, and H. Zhang PET/CT in the staging of the non-small-cell lung cancer J Biomed Biotechnol 2012 2012 783739
-
(2012)
J Biomed Biotechnol
, vol.2012
, pp. 783739
-
-
Chao, F.1
Zhang, H.2
|